Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Siniugina A"'
Autor:
Anastasia Rogova, Anna Kalyanova, Yulia Rogova, Maria Fedina, Alexandra Siniugina, Aydar Ishmukhametov, Galina Karganova
Publikováno v:
Brain Sciences, Vol 14, Iss 7, p 635 (2024)
Non-human primates, due to their similarities in immune response to humans, are the preferred model for studying infectious processes and any associated cognitive impairments. Behavioral tests are indispensable for investigating pathogenesis in neuro
Externí odkaz:
https://doaj.org/article/6ba6bff2129a4e81ab9087f797daefad
Autor:
A. N. Piniaeva, A. A. Kovpak, Y. Y. Ivin, S. H. Sandzhieva, A. A. Shishova, I. O. Tсelykh, V. E. Vasilenko, K. V. Kaa, Zh. H. Mazhed, Yu. Kh. Khapchaev, A. A. Siniugina, A. A. Ishmukhametov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 5, Pp 107-119 (2022)
Relevance. The production and quality control of any drugs are strictly regulated. In the case of antiviral vaccines, the requirements for their safety and protective activity are getting tougher every year. Vaccine manufacturers face three tasks: en
Externí odkaz:
https://doaj.org/article/ec8ee23723754b3b90aea36419e76609
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Victoria Illarionova, Anastasia Rogova, Ksenia Tuchynskaya, Viktor Volok, Yulia Rogova, Victoria Baryshnikova, Yuriy Turchenko, Alexander Litov, Anna Kalyanova, Alexandra Siniugina, Aydar Ishmukhametov, Galina Karganova
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1754 (2023)
Tick-borne encephalitis virus (TBEV) and Powassan virus (POWV) are neurotropic tick-borne orthoflaviviruses. They cause mostly asymptomatic infections in hosts, but severe forms with CNS involvement can occur. Studying the early stages of viral infec
Externí odkaz:
https://doaj.org/article/1142230b1f5b41babf66fac4d88be4ea
Autor:
Ilya V. Gordeychuk, Liubov I. Kozlovskaya, Aleksandra A. Siniugina, Nadezhda V. Yagovkina, Vladimir I. Kuzubov, Konstantin A. Zakharov, Viktor P. Volok, Maria S. Dodina, Larissa V. Gmyl, Natalya A. Korotina, Rostislav D. Theodorovich, Yulia I. Ulitina, Dmitry I. Vovk, Marina V. Alikova, Anna A. Kataeva, Anna V. Kalenskaya, Irina V. Solovjeva, Elena V. Tivanova, Larissa Y. Kondrasheva, Antonina A. Ploskireva, Vasiliy G. Akimkin, Ksenia A. Subbotina, Georgy M. Ignatyev, Anastasia K. Korduban, Elena Y. Shustova, Ekaterina O. Bayurova, Alla S. Zhitkevich, Daria V. Avdoshina, Anastasia N. Piniaeva, Anastasia A. Kovpak, Liliya P. Antonova, Yulia V. Rogova, Anna A. Shishova, Yury Y. Ivin, Svetlana E. Sotskova, Konstantin A. Chernov, Elena G. Ipatova, Ekaterina A. Korduban, Aydar A. Ishmukhametov
Publikováno v:
Viruses, Vol 15, Iss 9, p 1828 (2023)
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volu
Externí odkaz:
https://doaj.org/article/888b158eaf434d709bf07e578aead9e6
Autor:
Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Georgy M. Ignatyev, Ilya V. Gordeychuk, Viktor P. Volok, Yulia V. Rogova, Anna A. Shishova, Anastasia A. Kovpak, Yury Yu. Ivin, Liliya P. Antonova, Kirill M. Mefyod, Lyubov S. Prokosheva, Anna S. Sibirkina, Yuliya Yu. Tarasova, Ekaterina O. Bayurova, Olga S. Gancharova, Victoria V. Illarionova, Grigory S. Glukhov, Olga S. Sokolova, Konstantin V. Shaitan, Anastasia M. Moysenovich, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Larissa V. Gmyl, Elena G. Ipatova, Mikhail P. Kirpichnikov, Alexey M. Egorov, Aleksandra A. Siniugina, Aydar A. Ishmukhametov
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1790-1806 (2021)
The unprecedented in recent history global COVID-19 pandemic urged the implementation of all existing vaccine platforms to ensure the availability of the vaccines against COVID-19 to every country in the world. Despite the multitude of high-quality p
Externí odkaz:
https://doaj.org/article/25dd68ffe74e41b1a33bb195f5965272
Autor:
Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, Anastasia K. Korduban, Yury Y. Ivin, Anastasia A. Kovpak, Anastasia N. Piniaeva, Anna A. Shishova, Elena Y. Shustova, Yusuf K. Khapchaev, Galina G. Karganova, Alexandra A. Siniugina, Tatiana V. Pomaskina, Aleksandr A. Erovichenkov, Konstantin Chumakov, Aydar A. Ishmukhametov
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEffective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could sign
Externí odkaz:
https://doaj.org/article/bbeca342ee3848b59babc5aa3a6847f5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Evgeniy A. Tkachenko, Aydar A. Ishmukhametov, Tamara K. Dzagurova, Alla D. Bernshtein, Viacheslav G. Morozov, Alexandra A. Siniugina, Svetlana S. Kurashova, Alexandra S. Balkina, Petr E. Tkachenko, Detlev H. Kruger, Boris Klempa
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 12, Pp 2325-2328 (2019)
In Russia, 131,590 cases of hemorrhagic fever with renal syndrome caused by 6 different hantaviruses were reported during 2000–2017. Most cases, 98.4%, were reported in western Russia. The average case-fatality rate was 0.4%, and strong regional di
Externí odkaz:
https://doaj.org/article/1b0eab4564da4b84a8cbc2fbba4467a7
Autor:
Tamara K. Dzagurova, Alexandra A. Siniugina, Aidar A. Ishmukhametov, Maria S. Egorova, Svetlana S. Kurashova, Maria V. Balovneva, Andrey A. Deviatkin, Petr E. Tkachenko, Oksana A. Leonovich, Evgeny A. Tkachenko
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Hemorrhagic fever with renal syndrome (HFRS) is the most common natural focal disease in the Russian Federation with about 6–12 thousand cases annually. 97.7% of all HFRS cases in Russia are caused by the Puumala virus, 1.5%—by the Hantaan, Amur,
Externí odkaz:
https://doaj.org/article/6e1230b7a81b4a6297eecef7fab51db0